Thermo Fisher Scientific Inc. (LON:0R0H)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 123.61B |
| Revenue (ttm) | 33.14B |
| Net Income (ttm) | 5.03B |
| Shares Out | n/a |
| EPS (ttm) | 13.17 |
| PE Ratio | 24.57 |
| Forward PE | 18.94 |
| Dividend | 1.25 (0.31%) |
| Ex-Dividend Date | Mar 14, 2025 |
| Volume | 385 |
| Average Volume | 1,735 |
| Open | 412.51 |
| Previous Close | 410.85 |
| Day's Range | 404.55 - 412.51 |
| 52-Week Range | 416.66 - 603.14 |
| Beta | 0.83 |
| RSI | 29.84 |
| Earnings Date | Apr 23, 2025 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial numbers in USD Financial StatementsNews
10 Undervalued Dividend Growth Stocks: May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
3 Of The Cheapest High-Quality Stocks Money Can Buy
Geopolitical risks and economic uncertainty have battered markets, but I view this turmoil as an opportunity to buy high-quality, undervalued stocks. Despite volatility and weak earnings trends, I'm f...
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...
Is Thermo Fisher Scientific Gaining or Losing Market Support?
Thermo Fisher Scientific's (NYSE: TMO) short percent of float has risen 20.95% since its last report. The company recently reported that it has 4.79 million shares sold short , which is 1.27% of all ...
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to In...
Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan
Thermo Fisher plans $2 billion U.S. investment amid tariff concerns, while analysts lower price targets despite reaffirming positive ratings. Latest Ratings for ... Full story available on Benzinga.co...
Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan
Thermo Fisher Scientific Inc. TMO announced Thursday that it would invest an additional $2 billion in the U.S. over the next four years.
Thermo Fisher Scientific: Tariff And Policy Impacts Look Priced In
Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Read why I maintain my buy rating on TMO stock.
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers' Manufacturing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, str...
Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported first-quarter 2025 adjusted earnings per share of $5.15, beating the street view of $5.10 . Quarterly sales of $10.36 billion, almost f...
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher Scientific Inc. (NYSE: TMO) reported first-quarter 2025 adjusted earnings per share of $5.15 on Wednesday, beating the street view of $5.10 . Quarterly sales of $10.36 billion, almost f...
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher Scientific Inc. TMO reported first-quarter 2025 adjusted earnings per share of $5.15 on Wednesday, beating the street view of $5.10.
Thermo Fisher updates 2025 revenue guidance to $43.3B-$44.2B amid macroeconomic challenges
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2211161444-917f4a1085fe4071aa6736fed2b0e3bb.jpg)
Thermo Fisher Tops Q1 Estimates in 'Uncertain Macroeconomic Environment'
Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter results above analysts' expectations.
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in adjusted earnings. First-quarter revenue was $10.4 bill...
Buckle Up Buttercup - Here's What Every (Dividend) Investor Needs To Hear Right Now
Trade uncertainty, Fed drama, and stretched valuations are driving a powerful capital rotation away from U.S. assets, impacting the dollar, debt, and equities. Despite headwinds, I remain confident in...
Thermo Fisher beats estimates on steady demand for tools and services used in clinical research
Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by resilient demand for its products and services used for developing therapies.
Earnings Snapshot: Thermo Fisher Scientific Q1 tops estimates; to give updated FY outlook on earnings call
Thermo Fisher Scientific Non-GAAP EPS of $5.15 beats by $0.05, revenue of $10.36B beats by $130M
Thermo Fisher Scientific Reports First Quarter 2025 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2025. First ...
Earnings Scheduled For April 23, 2025
Companies Reporting Before The Bell • GATX (NYSE: GATX) is estimated to report quarterly earnings at $2.09 per share on revenue of $417.09 million. • First Hawaiian (NASDAQ: FHB) is expected to repo...
Earnings Preview For Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE: TMO) is set to give its latest quarterly earnings report on Wednesday, 2025-04-23. Here's what investors need to know before the announcement. Analysts estimate that T...
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'
Danaher Corp (NYSE: DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion . Non-GAAP core revenue was flat compared to the...